R. Michael Carruthers
Overview
R. Michael Carruthers received an average of $1M in total compensation, including $292K in salary, at Nivalis Therapeutics from 2015 to 2017. R Carruthers also received an average of $631K at Array BioPharma from 2007 to 2015.
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2009
- 2008
Nivalis TherapeuticsFormer Interim President and Chief Financial Officer
Nivalis TherapeuticsFormer Interim President and Chief Financial Officer
Nivalis TherapeuticsChief Financial Officer
Array BioPharmaFormer Chief Financial Officer
Array BioPharmaFormer Chief Financial Officer
Array BioPharmaFormer Chief Financial Officer
Array BioPharmaChief Financial Officer
Array BioPharmaChief Financial Officer
Array BioPharmaChief Financial Officer
Array BioPharmaChief Financial Officer
Source: SEC filings on April 24, 2018, March 21, 2016, September 18, 2015, September 13, 2013, and September 18, 2009.
Related executives
We found 21 more executives who work or worked at Nivalis Therapeutics and Array BioPharma.
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
Stanford Peng
Nivalis Therapeutics
President and Head of Research and Development
Zelanna Goldberg
Nivalis Therapeutics
Chief Medical Officer
Paul Rickey
Nivalis Therapeutics
Chief Financial Officer
Ron Squarer
Array BioPharma
Chief Executive Officer
Curtis Oltmans
Array BioPharma
General Counsel
Andrew Robbins
Array BioPharma
Chief Operating Officer
Victor Sandor
Array BioPharma